RESEARCHER PROFILE
Goce B. Spasovski
← Back to Ss. Cyril and Methodius University in Skopje
G
Ss. Cyril and Methodius University in Skopje
Goce B. Spasovski works in Dialysis and Renal Disease Management, Chronic Kidney Disease and Diabetes, Renal Transplantation Outcomes and Treatments, Parathyroid Disorders and Treatments, Organ Donation and Transplantation. Recorded institutional associations include Ss. Cyril and Methodius University in Skopje.
359Publications
9,953Citations
41H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Clinical practice guideline on diagnosis and treatment of hyponatraemia
2014 · 1,020 citationsClinical practice guideline on diagnosis and treatment of hyponatraemia
2014 · 855 citationsChronic kidney disease as cause of cardiovascular morbidity and mortality
2005 · 613 citationsClinical practice guideline on diagnosis and treatment of hyponatraemia
2014 · 579 citationsRecommendations for Biomarker Identification and Qualification in Clinical Proteomics
2010 · 334 citationsA multicenter study on the effects of lanthanum carbonate (Fosrenol™) and calcium carbonate on renal bone disease in dialysis patients
2003 · 326 citationsEuropean Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care: FIGURE 1.
2014 · 309 citationsEarly detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial
2020 · 262 citationsDiagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides
2015 · 242 citationsEuropean Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4–G5D
2020 · 207 citationsBone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism
2014 · 181 citationsImplementation of proteomic biomarkers: making it work
2012 · 169 citationsEvolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up
2006 · 162 citationsSpectrum of renal bone disease in end-stage renal failure patients not yet on dialysis
2003 · 135 citationsData Sharing Under the General Data Protection Regulation
2021 · 133 citationsProteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial
2016 · 122 citationsUseful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients
2003 · 117 citationsMulticentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy
2014 · 113 citationsGuideline
2013 · 107 citationsUnderstanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
2016 · 105 citationsChronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?
2021 · 105 citationsAssociation of kidney fibrosis with urinary peptides: a path towards non-invasive liquid biopsies?
2017 · 97 citationsSerum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients
2019 · 94 citationsSources of urinary proteins and their analysis by urinary proteomics for the detection of biomarkers of disease
2009 · 84 citationsMild cognitive impairment and kidney disease: clinical aspects
2019 · 81 citations
